Standard BioTools Newsroom

TD Cowen Maintains Standard BioTools(LAB.US) With Buy Rating, Maintains Target Price $2.5

Moomoo NewsOct 31 08:31 ET

TD Cowen Maintains Standard BioTools(LAB.US) With Buy Rating, Cuts Target Price to $2.5

Moomoo NewsOct 30 21:31 ET

TD Cowen Maintains Standard BioTools(LAB.US) With Buy Rating, Maintains Target Price $2.75

Moomoo NewsSep 16 08:31 ET

Standard BioTools (LAB) Receives a Buy From TD Cowen

TipRanksSep 16 07:48 ET

TD Cowen Maintains Buy on Standard BioTools, Lowers Price Target to $2.75

BenzingaAug 1 14:28 ET

TD Cowen Maintains Standard BioTools(LAB.US) With Buy Rating, Cuts Target Price to $2.75

Moomoo NewsAug 1 02:32 ET

Maintaining a Buy Rating for Standard BioTools: Overcoming Short-Term Challenges With Long-Term Growth Potential

TipRanksAug 1 01:19 ET

Standard BioTools Analyst Ratings

BenzingaApr 16 07:17 ET

Analysts Offer Insights on Healthcare Companies: Bausch Health Companies (BHC) and Standard BioTools (LAB)

TipRanksApr 4 08:20 ET

Standard BioTools Analyst Ratings

BenzingaApr 4 07:22 ET

KeyBanc Initiates Standard BioTools at Overweight With $4 Price Target, Sees 'Attractively Valued Way to Invest' in Life Sciences Technology

MT NewswiresJul 12, 2023 08:18 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Centene (CNC) and Standard BioTools (LAB)

TipRanksJul 12, 2023 04:30 ET

Keybanc Initiates Coverage On Standard BioTools With Overweight Rating, Announces Price Target of $4

BenzingaJul 12, 2023 04:29 ET

Standard BioTools Analyst Ratings

BenzingaJul 12, 2023 04:28 ET